Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

LifePoint Hospitals Inc Issues FY 2013 Guidance; Revenue Guidance Above Analysts' Estimates; EPS Guidance Below Analysts' Estimates


Friday, 15 Feb 2013 07:00am EST 

LifePoint Hospitals Inc announced that for fiscal 2013, it expects net revenue in the range of $3.65-$3.75 billion, adjusted EBITDA in the range of $540-$570 million and diluted EPS in the range of $2.73-$3.11. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $3.60 billion, EBITDA of $568 million and EPS of $3.25 for fiscal 2013. 

Company Quote

74.65
0.15 +0.20%
27 Aug 2014